Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012

Abstract

Stockholm University and WHO, within a project funded by the European Commission (EVK2-2000-00070), reviewed the impacts of climate change and adaptation on Lyme borreliosis (LB) in Europe.

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area

“…Data can be collected through repeated cross-sectional retrospective surveys, as has been implemented in the Netherlands and some other countries by means of GP surveys [5,11-15]. Other options would be implementation through prospective or retrospective sentinels among hospitals and GP practices [16-18]. These options work mainly on a voluntary basis and are shown to provide high response rates and good regional and national estimates to identify temporal and spatial trends [12].…”

“…At lower administrative levels or in a sentinel setting, surveillance of neuroborreliosis may be relatively insensitive, since neuroborreliosis is a relatively rare outcome compared with EM, occurring in 3–38% of LB cases, whereas EM occurs in 60–95% of all diagnosed LB manifestations [11,16,17,24] (Table 2). …”

“…If implemented in a surveillance system, case definitions should be based both on clinical and laboratory diagnostic criteria [2,25]. Data collection can be performed through reporting GPs or other physicians and complemented by laboratory reporting e.g [5,11,16]. Nationwide and comprehensive surveillance systems, when compared with regional and sentinel approaches, will provide better information on the proportion of the occurrence of each LB manifestation (Table 2).…”

Scouts, forests, and ticks: Impact of landscapes on human-tick contacts

“…Tick-borne diseases (TBD) are a public health issue worldwide as trends in several studies indicate that their incidence has increased in Europe and America over the past two decades (Bacon et al, 2008;Lindgren and Jaenson, 2006;Randolph, 2004;Vandenesch et al, 2014). Therefore several questions arise, namely, why this emergence?…”

Epidemiology and cost of hospital care for Lyme borreliosis in Germany: Lessons from a health care utilization database analysis

“…Currently, available official data on LB incidence in Germany range between 77.6/100,000 for the state of Brandenburg and 5.7/100,000 for the urban area of Berlin (Fülöp and Poggensee, 2008). In the absence of nationwide notification data it seems attractive to provisionally rely on other sources of data with comprehensive coverage such as hospital discharge data used in a recent study from France (Vandenesch et al, 2014) or claims data of health insurance companies. Following the latter approach, a study reported an average annual incidence of 261/100,000 for the diagnosis "LB" (Müller et al, 2012).…”